Double-blind controlled trial of amylopectin sulphate (Depepsen) in the symptomatic treatment of duodenal ulcer.

Abstract
In a double-blind controlled trial amylopectin sulfate (Depepsen) had no significant advantage over placebo in the symptomatic treatment of duodenal ulcer [human].

This publication has 9 references indexed in Scilit: